Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 6/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | PDE6D | O43924 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22484956 | 0.98 | PDE6D (0.38) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL22871622 | 0.97 | L3MBTL1 (0.35) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL19071919 | 0.87 | MEN1 (0.33) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17640410 | 0.84 | NR1H3 (0.38) | ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL17640535 | 0.84 | NR1H4 (0.50) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL20964164 | 0.83 | ALDH1A1 (0.34) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL17640500 | 0.83 | SMN1; SMN2 (0.39) | ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL17640493 | 0.83 | SMN1; SMN2 (0.39) | ALDH1A1LMNANPC1RAB9A | |
| SCHEMBL17640559 | 0.83 | CYP19A1 (0.42) | MEN1KMT2AMAPTADORA2AADORA1 | |
| SCHEMBL21702834 | 0.82 | PDE6D (0.37) | L3MBTL1MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357169-A1 | ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-11-09 | — | — | US | disclosed |
| US-11680059-B2 | Organic mixture and application thereof in organic electronic devices | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2023-06-20 | — | — | US | disclosed |
| US-20200317646-A1 | ORGANIC MIXTURE AND APPLICATION THEREOF IN ORGANIC ELECTRONIC DEVICES | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357169-A1 | ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES | SLCO1B3, SLCO2B1, SLCO2A1 | L3MBTL1 1693/4885MEN1 482/4885KMT2A 2009/4885 |
| US-20200317646-A1 | ORGANIC MIXTURE AND APPLICATION THEREOF IN ORGANIC ELECTRONIC DEVICES | OCIAD1, OCIAD2, SORD | L3MBTL1 2981/4885MEN1 3011/4885KMT2A 4460/4885 |
| US-11680059-B2 | Organic mixture and application thereof in organic electronic devices | OCIAD1, OCIAD2, SORD | L3MBTL1 2981/4885MEN1 3011/4885KMT2A 4460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.